Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gelofusine versus hydroxyethyl starch priming in CABG surgery
2011-000156-42Phase 4Completed
- Sponsor
- Amphia Ziekenhuis
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in coronary arteriosclerosis comparing Ringer lactate + Gelofusine priming with Ringer lactate + hydroxyethyl starch 130/0.4 priming (2 arms). Primary endpoints: Thorax drain production at 1 hour, Thorax drain production at 3 hours and 3 more. Started Jan 2011; status: completed.
02
Drugs
gelatinhetastarchlactated ringer's solution
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2011-000156-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000156-42.